BASF refuses Evonik merger
Statements (10 of 18)
- Neutral
Evonik is refusing to merge with BASF, which would create a chemical industry conglomerate with annual revenue of around 74 billion euros.
- Bearish
Evonik management accuses BASF of exploiting the illness of Evonik CEO.
- Bullish
Evonik is strengthening its position in the poker market by acquiring BASF
- Bullish
Evonik reports strong growth in its acquisition of BASF
- Bearish
BASF attempted to acquire Evonik for $12.5 billion but was rejected.
- Bearish
Evonik rejected Basf's revised acquisition offer of US$12.5 billion.
- Bearish
Evonik has terminated a new BASF order
- Bearish
Evonik declines the new BASF acquisition offer.
- Neutral
Evonik will das verbesserte Übernahmeangebot des Konkurrenten BASF ablehnen
- Bearish
BASF is facing pressure from its CEO amid a potential takeover offer from Evonik.
8 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=624fcf7c-de0f-4fc5-b11a-71268edcdcda Get a free API key ↗